IMUX logo
NASDAQ · IMUXBiotechnologyUpdated Nov 2, 2026

Immunic, Inc. ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for Immunic, Inc. (IMUX) is -157.89%

According to Immunic, Inc.’s latest financial reports and current stock price. The company's current ROE is -157.89%. This represents a change of 23.44% compared to the average of -0.67% of the last 4 quarters.

Immunic, Inc. (IMUX) Historical ROE (quarterly & annually)

How has IMUX ROE performed in the past?

The mean historical ROE of Immunic, Inc. over the last ten years is -18.71%. The current -157.89% ROE has changed 743.96% with respect to the historical average. Over the past ten years (40 quarters), IMUX's ROE was at its highest in in the March 2025 quarter at 481.80%. The ROE was at its lowest in in the September 2025 quarter at -243.63%.

Quarterly (TTM)
Annual

Average

-18.71%

Median

-88.59%

Minimum

-545.37%

Maximum

1.46%

Immunic, Inc. (IMUX) ROE by Quarter and Year

Discovering the peaks and valleys of Immunic, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 220.71%

Maximum Annual ROE = 1.46%

Minimum Annual Increase = -367.01%

Minimum Annual ROE = -545.37%

Quarterly (TTM)
Annual
YearROEChange
20251.46%-367.01%
2024-545.37%68.55%
2023-323.57%205.50%
2022-105.91%44.85%
2021-73.12%163.77%
2020-27.72%-53.54%
2019-59.67%-82.12%
2018-333.75%220.71%
2017-104.06%48.46%
2016-70.10%10.93%

Immunic, Inc. (IMUX) Average ROE

How has IMUX ROE performed in the past?

The current ROE of Immunic, Inc. (IMUX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

195.75%

5-year avg

81.64%

10-year avg

-18.71%

Immunic, Inc. (IMUX) ROE vs. Peers

How is IMUX’s ROE compared to its peers?

Immunic, Inc.’s ROE is greater than PMV Pharmaceuticals, Inc. (-78.11%), greater than Relmada Therapeutics, Inc. (-47.52%), greater than Acrivon Therapeutics, Inc. Common Stock (-70.14%), greater than Lite Strategy, Inc. (-97.27%), greater than Repare Therapeutics Inc. (-11.96%), less than Vaxart, Inc. (53.04%), greater than TScan Therapeutics, Inc. (-108.72%), greater than Biomea Fusion, Inc. (-171.19%), greater than Cibus, Inc. (-320.60%), greater than Adicet Bio, Inc. (-74.90%),

Build a custom stock screener for Immunic, Inc. (IMUX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunic, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immunic, Inc. (IMUX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immunic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Immunic, Inc.'s ROE?

How is the ROE calculated for Immunic, Inc. (IMUX)?

What is the highest ROE for Immunic, Inc. (IMUX)?

What is the 3-year average ROE for Immunic, Inc. (IMUX)?

What is the 5-year average ROE for Immunic, Inc. (IMUX)?

How does the current ROE for Immunic, Inc. (IMUX) compare to its historical average?